Amyotrophic Lateral Sclerosis Non-invasive Ventilation Exchange | MicrobiomeTrials← Back to trialsNCT05837507
Amyotrophic Lateral Sclerosis Non-invasive Ventilation Exchange
TERMINATEDNAINTERVENTIONAL
Trial Details
Start: 2023-07-05Est. Completion: 2025-10-21
Enrollment target: 43 participants Locations- Uh Montpellier, Montpellier, Montpellier, France
- Clinique du Millénaire, Montpellier, France
Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis (ALS)Chronic Respiratory FailureNeuromuscular Disease PatientsNeuromuscular DiseaseRespiratory InsufficiencyRespiratory Insufficiency Requiring Mechanical VentilationPositive Pressure VentilationNon-invasive VentilationNon-invasive Ventilation SupportNon-invasive Ventilatory Support
Amyotrophic lateral sclerosis (ALS) is a disease that causes weakness of the muscles of the body. The disease can eventu…
Hershey, United StatesEst. completion May 2029
Phase 2
Recruiting
Amyotrophic Lateral Sclerosis
The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyo…
Phoenix, United StatesEst. completion Oct 2026